Speech-Language Pathologists in Boulder, CO Accepting Medicare

177 Speech-Language Pathologists found. Showing 1 - 20

Catharine Jean Lauderbaugh, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2060 Floral Dr, Boulder, CO 80304 Phone: 650-387-3679

Alison Maasdorf Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 720-561-6561

Mrs. Andrea Lorene Mann, M.A. CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Pine Needle Rd, Boulder, CO 80304 Phone: 303-449-0880    Fax: 303-938-8045

Chris Morton Rowinski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 N Fork Ct, Boulder, CO 80301 Phone: 303-817-5055

Dr. Rosemary J Mcknight, MBCHB, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 303-447-1010

Maria Madjar, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 303-447-1010

Natalie Rufa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 937-597-1545

Rebecca Mcneil Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 720-561-7000

Susan Morrison Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3605 Table Mesa Dr, Suite R-315, Boulder, CO 80305 Phone: 805-290-2805

Cassandra Mcclenaghan, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2845 Broadway St Apt 201, Boulder, CO 80304 Phone: 831-224-3002

Christina Riseman, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Slhc, 2501 Kittredge Loop Rd., 409 Ucb, Boulder, CO 80309 Phone: 303-492-5375

Carolyn Ann Corry, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 415-637-4272

Emily Simon, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 262-490-5195

Associated Stuttering Treatment -ramig Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2885 Aurora Ave, Boulder, CO 80303 Phone: 303-247-1632

Mrs. Alexandra B Carrillo, MA-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2501 Kittredge Loop Rd 409 Ucb, Boulder, CO 80309 Phone: 303-492-5375    Fax: 303-492-6560

Holly Kleiber Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Slhc 2501 Kittredge Loop Rd 409 Ucb, Boulder, CO 80309 Phone: 303-492-5375

Jamie Lynne Ragsdale, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 N Fork Ct, Boulder, CO 80301 Phone: 303-817-5055

Travis Althouse Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Gunpark Dr Ste 103, Boulder, CO 80301 Phone: 303-530-9191

Ms. Kathy Nunemaker, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4105 Gilpin Dr, Boulder, CO 80303 Phone: 303-931-8313    Fax: 303-543-8283

Dan P. Mclellan Ltd Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5520 Northfork Ct, Boulder, CO 80301 Phone: 303-817-5055    Fax: 303-914-8400

News Archive

Artificial intelligence can detect serious eye disease in diabetic patients

Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown that the technology can accurately detect serious eye disease among those with diabetes (retinopathy) and could halve the human workload associated with screening for diabetic eye disease, saving millions of pounds annually.

DMC concludes Protege Phase 3 clinical trial for type 1 diabetes lacks efficacy

MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.

AACR to host its first Frontiers in Basic Cancer Research Meeting

The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.

Teenagers being bombarded by alchohol advertising

Alcohol advertising on television, and youth exposure to it, grew substantially in 2002 from 2001, and although new industry marketing codes were announced in 2003, they will still allow for substantial youth overexposure to alcohol ads, according to a study released today by the Center on Alcohol Marketing and Youth at Georgetown University.

Read more Medical News

› Verified 4 days ago

• 1(current)
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9